(2026). Tirzepatide reduced alcohol use in three patients with alcohol-associated liver disease, type 2 diabetes, and obesity. Endocrinology, Diabetes & Metabolism Case Reports.
Successfully copied to clipboard
Copying to clipboard failed
Chicago Style (17th ed.) Citation
"Tirzepatide Reduced Alcohol Use in Three Patients with Alcohol-associated Liver Disease, Type 2 Diabetes, and Obesity."
Endocrinology, Diabetes & Metabolism Case Reports 2026.
Successfully copied to clipboard
Copying to clipboard failed
MLA (9th ed.) Citation
"Tirzepatide Reduced Alcohol Use in Three Patients with Alcohol-associated Liver Disease, Type 2 Diabetes, and Obesity."
Endocrinology, Diabetes & Metabolism Case Reports, 2026.
Successfully copied to clipboard
Copying to clipboard failed
Warning: These citations may not always be 100% accurate.